Price $232.59 |
Market Cap
14.07B
|
Sector Health Care |
Div. Growth
-
|
|
P/E
28.5
|
P/B
-
|
P/S
6.17
|
Dividend %
-
|
|
P/CF
-
|
P/FCF
26.7
|
Op. Cash Flow
714.9K
|
FCF
8.5
|
|
Op. Margin
26.90%
|
Net Margin
22.00%
|
ROE
-255.90%
|
ROI
42.30%
|
|
ROA
19.10%
|
EPS Growth
-1.60%
|
Current Ratio
2.2
|
Debt/Equity
-
|
| Company | Price | P/E | Div. Yield | Market Cap ($Mil) | Rating |
|---|---|---|---|---|---|
| Zimmer Biomet Holdings Inc (ZBH) | $146.31 | - | 0.60% | 31.03B | Strong Buy |
| Elite Pharmaceuticals Inc (ELTP) | $0.05 | - | - | 55.5M | Strong Buy |
| Great Elm Capital Group Inc (GEC) | $2.66 | - | - | 71.8M | Strong Buy |
| Harbor Diversified Inc (HRBR) | $0.21 | - | - | 13.4M | Strong Buy |
| Harvard Bioscience, Inc. (HBIO) | $3.89 | - | - | 147.3M | Strong Buy |
Please note that all recommendations are based on our model's results and do not represent our personal opinion. The stock Rating process is purely mechanical.
All analysis relies on publicly available financial information. Learn More
